Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 796

1.

Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines.

Shai I, Rimm EB, Hankinson SE, Curhan G, Manson JE, Rifai N, Stampfer MJ, Ma J.

Circulation. 2004 Nov 2;110(18):2824-30. Epub 2004 Oct 18.

2.

Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes.

Schulze MB, Shai I, Manson JE, Li T, Rifai N, Jiang R, Hu FB.

Diabetologia. 2004 Dec;47(12):2129-36. Epub 2004 Dec 15.

PMID:
15662553
3.

Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.

Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB.

Circulation. 2005 Nov 29;112(22):3375-83.

4.

Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.

Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, Patsch W; Atherosclerosis Risk in Communities Study Group.

Circulation. 2001 Sep 4;104(10):1108-13.

5.

A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.

Li JZ, Chen ML, Wang S, Dong J, Zeng P, Hou LW.

Chin Med J (Engl). 2004 Feb;117(2):163-7.

PMID:
14975195
6.

Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?

Wu T, Willett WC, Rifai N, Shai I, Manson JE, Rimm EB.

J Am Coll Cardiol. 2006 Sep 5;48(5):973-9. Epub 2006 Aug 17.

7.

Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes.

Liu J, Sempos C, Donahue RP, Dorn J, Trevisan M, Grundy SM.

Diabetes Care. 2005 Aug;28(8):1916-21.

PMID:
16043732
8.

Serum lipids and incidence of coronary heart disease. Findings from the Systolic Hypertension in the Elderly Program (SHEP).

Frost PH, Davis BR, Burlando AJ, Curb JD, Guthrie GP Jr, Isaacsohn JL, Wassertheil-Smoller S, Wilson AC, Stamler J.

Circulation. 1996 Nov 15;94(10):2381-8.

9.
10.

VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial.

Sacks FM, Alaupovic P, Moye LA, Cole TG, Sussex B, Stampfer MJ, Pfeffer MA, Braunwald E.

Circulation. 2000 Oct 17;102(16):1886-92.

11.

Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities.

Abdu TA, Neary R, Elhadd TA, Akber M, Clayton RN.

Clin Endocrinol (Oxf). 2001 Aug;55(2):209-16. Erratum in: Clin Endocrinol (Oxf) 2001 Nov;55(5):699.

PMID:
11531927
12.

Risk of cardiovascular events in patients at optimal values for combined lipid parameters.

Stanek EJ, Sarawate C, Willey VJ, Charland SL, Cziraky MJ.

Curr Med Res Opin. 2007 Mar;23(3):553-63.

PMID:
17357251
13.
14.

Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM.

Lehto S, Rönnemaa T, Haffner SM, Pyörälä K, Kallio V, Laakso M.

Diabetes. 1997 Aug;46(8):1354-9.

PMID:
9231662
15.

Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?

Simes RJ, Marschner IC, Hunt D, Colquhoun D, Sullivan D, Stewart RA, Hague W, Keech A, Thompson P, White H, Shaw J, Tonkin A; LIPID Study Investigators.

Circulation. 2002 Mar 12;105(10):1162-9.

16.

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.

Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Mänttäri M, Heinonen OP, Frick MH.

Circulation. 1992 Jan;85(1):37-45.

PMID:
1728471
17.
18.

Associations between serum lipids and causes of mortality in a cohort of 3,499 urban Thais: The Electricity Generating Authority of Thailand (EGAT) study.

Sritara P, Patoomanunt P, Woodward M, Narksawat K, Tulyadachanon S, Ratanachaiwong W, Sritara C, Barzi F, Yamwong S, Tanomsup S.

Angiology. 2007 Dec-2008 Jan;58(6):757-63. doi: 10.1177/0003319707304042.

PMID:
18216384
19.

Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population.

Wang TD, Chen WJ, Chien KL, Seh-Yi Su SS, Hsu HC, Chen MF, Liau CS, Lee YT.

Am J Cardiol. 2001 Oct 1;88(7):737-43.

PMID:
11589839
20.

Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors.

Sacks FM, Tonkin AM, Craven T, Pfeffer MA, Shepherd J, Keech A, Furberg CD, Braunwald E.

Circulation. 2002 Mar 26;105(12):1424-8.

Supplemental Content

Support Center